Medicine
fromNews Center
3 days agoNovel Biomarker May Predict Immunotherapy Resistance - News Center
USP22 suppresses MHC-I–mediated neoantigen presentation, driving immune checkpoint blockade resistance and representing a potential therapeutic target to restore antitumor T-cell responses.